Kyntra Bio, Inc. (KYNB)
NASDAQ: KYNB · Real-Time Price · USD
8.22
-0.33 (-3.86%)
Sep 8, 2026, 4:00 PM EDT - Market closed
Kyntra Bio Market Cap
Kyntra Bio has a market cap or net worth of $33.28 million as of September 8, 2026. Its market cap has decreased by -31.93% in one year.
Market Cap
33.28M
Enterprise Value
-58.03M
1-Year Change
-31.93%
Ranking
Category
Stock Price
$8.22
ChartMarket Cap Chart
Since November 14, 2014, Kyntra Bio's market cap has decreased from $1.22B to $33.28M, a decrease of -97.28%. That is a compound annual growth rate of -26.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 33.30M | -6.20% |
| Dec 31, 2025 | 35.50M | -33.52% |
| Dec 31, 2024 | 53.40M | -38.76% |
| Dec 29, 2023 | 87.20M | -94.21% |
| Dec 30, 2022 | 1.51B | 15.15% |
| Dec 31, 2021 | 1.31B | -61.28% |
| Dec 31, 2020 | 3.38B | -9.80% |
| Dec 31, 2019 | 3.74B | -4.85% |
| Dec 31, 2018 | 3.93B | 1.17% |
| Dec 29, 2017 | 3.89B | 187.60% |
| Dec 30, 2016 | 1.35B | -27.68% |
| Dec 31, 2015 | 1.87B | 22.78% |
| Dec 31, 2014 | 1.52B | 24.27% |
| Nov 14, 2014 | 1.22B | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aligos Therapeutics | 38.78M |
| CervoMed | 38.70M |
| NextCure | 35.79M |
| Actuate Therapeutics | 35.54M |
| TransCode Therapeutics | 34.88M |
| Context Therapeutics | 33.23M |
| Actinium Pharmaceuticals | 32.38M |
| Quince Therapeutics | 31.85M |